ACI

Archean Chemical Industries Financial Results

₹476.70+0.46%
Market cap
₹5,885 crore
P/E
60.8
P/B
3.04
ROE
5.6%
Dividend yield
1.20%

For the year ended Mar 2023, Archean Chemical Industries reported revenue of ₹1,440 crore and net profit of ₹383 crore, against ₹1,304 crore and ₹319 crore a year earlier.

Archean Chemical Industries annual profit and loss

Financial years, newest first. TTM = trailing twelve months.

Archean Chemical Industries annual profit and loss (₹ crore)
ItemMar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue1,4401,3041,0391,0771,116
Expenses806840725838888
Operating profit634464315239228
Operating margin %44%36%30%22%20%
Other income4040-52424
Interest94772326
Depreciation6970799393
Profit before tax512427224147133
Tax %25%25%28%28%28%
Net profit38331916210596
EPS (₹)31.0925.8513.148.667.84
Dividend payout %—————

Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.

Archean Chemical Industries financial results — frequently asked questions

What is Archean Chemical Industries' annual revenue and net profit?

For the financial year ended Mar 2023, Archean Chemical Industries' revenue was ₹1,440 crore and net profit ₹383 crore; net profit rose 20.06% from ₹319 crore in Mar 2024.

How fast has Archean Chemical Industries grown over three years?

From Mar 2026 to Mar 2023, Archean Chemical Industries' revenue grew at a compound annual rate of 10.2% and net profit at 53.9%. Past growth does not indicate future results.

What is the EPS of Archean Chemical Industries?

Annual EPS for Mar 2023 was ₹31.09.

Are these figures consolidated or standalone?

They are consolidated figures as reported by the company, in ₹ crore. Trailing-twelve-month and half-year columns are labelled separately and are not counted as financial years.

Same Data For Peers

Trade Archean Chemical Industries With ATS

Track ACI live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.